Haibo Lu

发表

Qualitative Ras pathway signature for cetuximab therapy reveals resistant mechanism in colorectal cancer

Wenyuan Zhao, Zheng Guo, Yelin Fu, 2020, The FEBS journal.

Ginkgolide B enhances gemcitabine sensitivity in pancreatic cancer cell lines via inhibiting PAFR/NF-кB pathway.

Yanqiao Zhang, Haibo Lu, Chao Liu, 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Integrated analysis of the prognostic role of the lymph node ratio in node-positive gastric cancer: A meta-analysis.

Yan Zhang, Shipeng Shang, Jiang Zhu, 2018, International journal of surgery.

A Ferroptosis-Related LncRNA Signature Associated with Prognosis, Tumor Immune Environment, and Genome Instability in Hepatocellular Carcinoma

Haibo Lu, J. Lian, Chao Zhang, 2022, Computational and mathematical methods in medicine.

Real-world survival of colon cancer after radical surgery: A single-institutional retrospective analysis

Shuli Tang, Haibo Lu, Xin Wang, 2022, Frontiers in Oncology.

DNA Methylation-Specific Analysis of G Protein-Coupled Receptor-Related Genes in Pan-Cancer

Wenhui Xue, Jiyun Zhao, Haibo Lu, 2022, Genes.

Intrinsic resistance and efficacy of immunotherapy in microsatellite instability-high colorectal cancer: A systematic review and meta-analysis.

Xin Wang, Shuli Tang, Haibo Lu, 2022, Bosnian journal of basic medical sciences.

Case report: 10-year survival of a patient with a primary hepatic gastrointestinal stromal tumor

M. Feng, Shumei Zhang, Haibo Lu, 2022, Frontiers in Oncology.

IGFBP2/FAK Pathway Is Causally Associated with Dasatinib Resistance in Non–Small Cell Lung Cancer Cells

J. Minna, J. Roth, S. Swisher, 2013, Molecular Cancer Therapeutics.

Insulin-Like Growth Factor Binding Protein-2 Level Is Increased in Blood of Lung Cancer Patients and Associated with Poor Survival

Xifeng Wu, J. Roth, S. Swisher, 2013, PloS one.

IGFBP 2 / FAK pathway is causally associated with dasatinib resistance in non-small Cell Lung Cancer Cells

J. Minna, J. Roth, S. Swisher, 2013 .

Selective antitumor activity of ibrutinib in EGFR-mutant non-small cell lung cancer cells.

Michael L. Wang, J. Minna, J. Roth, 2014, Journal of the National Cancer Institute.

Development of a method for identifying and functionally analyzing allele-specific DNA methylation based on BS-seq data.

Jiang Zhu, Shumei Zhang, Wenhua Lv, 2019, Epigenomics.

Neoadjuvant immunotherapy for colorectal cancer: Right regimens, right patients, right directions?

Yutian Zhao, S. Ji, Jiahao Zhu, 2023, Frontiers in Immunology.

Dual silencing of EGFR and HER2 enhances the sensitivity of gastric cancer cells to gefitinib

Jiaxin Zheng, Qiuying Sun, Rui Zhang, 2018, Molecular carcinogenesis.

Feature article: The signature of pharmaceutical sensitivity based on ctDNA mutation in eleven cancers

Shumei Zhang, Yan Zhang, Haibo Lu, 2020, Experimental biology and medicine.

Accurate Prediction of Prognosis by Integrating Clinical and Molecular Characteristics in Colon Cancer

Yan Zhang, Dianshuang Zhou, Haibo Lu, 2021, Frontiers in Cell and Developmental Biology.

Survival rate of colorectal cancer in China: A systematic review and meta-analysis

Shuli Tang, Haibo Lu, Xin Wang, 2023, Frontiers in Oncology.

Role of endogenous and exogenous antioxidants in risk of six cancers: evidence from the Mendelian randomization study

Xin Wang, S. Ji, Chenyang Li, 2023, Frontiers in Pharmacology.

Unraveling temporal and spatial biomarkers of epithelial-mesenchymal transition in colorectal cancer: insights into the crucial role of immunosuppressive cells

Mingzhe Li, Cuicui Chai, Mingze Yan, 2023, Journal of Translational Medicine.

Dynamic monitoring of serum CEA and CA19-9 predicts the prognosis of postoperative stage II colon cancer.

Haibo Lu, Benjie Xu, Xiangyi Pang, 2023, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.